Aseptic meningitis following therapy with immune globulins: a combination of product features and patient characteristics?

摘要

BACKGROUNDAseptic meningitis (AM) represents a recognized side effect of immune globulin (IG) therapy and may warrant additional diagnostic procedures and therapy with anti-infective drugs until a definite diagnosis can be established. Although, to date, only small case series have been published, the objective of the current study was to investigate a large case series of patients with AM.